Daily Watch List: Dr Pepper Snapple Group (NYSE:DPS), Tumi Holdings (NYSE:TUMI), XBiotech (NASDAQ:XBIT), Kinder Morgan (NYSE:KMI)

Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) shares increased 0.66% in last trading session and ended the day at $3.05. Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) quarterly performance is 74.29%.

Conatus Pharmaceuticals Inc (NASDAQ:CNAT) announced the acceptance of two abstracts for presentation at The International Liver Congress™ 2016, the Annual Meeting of the European Association for the Study of the Liver (EASL) in Barcelona, Spain, April 13-17, 2016.

Dr Pepper Snapple Group, Inc. (NYSE:DPS) ended the last trading day at $88.43. Company weekly volatility is calculated as 1.36% and price to cash ratio as 18.33. Dr Pepper Snapple Group, Inc. (NYSE:DPS) showed a weekly performance of -3.38%.

Dr Pepper Snapple Group, Inc. (NYSE:DPS) will issue its first quarter 2016 financial results on Wednesday, April 27, before the market opens.

On 15 April, Tumi Holdings, Inc. (NYSE:TUMI) shares moved down -0.07% and was closed at $26.67. TUMI EPS growth in last 5 year was 260.20%. Tumi Holdings, Inc. (NYSE:TUMI) year to date (YTD) performance is 60.37%.

Vetr upgraded shares of Tumi Holdings Inc (NYSE:TUMI) from a hold rating to a buy rating in a research note published on Wednesday, Market Beat Ratings reports. They currently have $28.21 price target on the stock.

XBiotech, Inc. (NASDAQ:XBIT) shares advanced 14.27% in last trading session and ended the day at $13.77. XBIT has a return on assets of -36.20%. XBiotech, Inc. (NASDAQ:XBIT) quarterly performance is 82.63%.

XBiotech, Inc. (NASDAQ:XBIT) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted accelerated review for Marketing Authorization of Xilonix, the Company’s first-in-class True Human monoclonal (IgG1k) antibody treatment for advanced colorectal cancer. The CHMP grants accelerated review for medicines deemed to be of public health importance and that represent therapeutic innovation.

Kinder Morgan, Inc. (NYSE:KMI) caters to the Basic Materials space. It has a net profit margin of 1.60% and weekly performance is 1.23%. On the last day of trading company shares ended up at $18.16. Kinder Morgan, Inc. (NYSE:KMI) distance from 50-day simple moving average (SMA50) is 3.76%.

Kinder Morgan, Inc. (NYSE:KMI) officials Phil Kennedy and Andy Weygant assured Hayden his irrigation line would be protected and repaired if damaged.